Doxorubicin and interferon: rationale and clinical experience.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D004317:Doxorubicin / Q000008:administration & dosage*; D006801:Humans; D007370:Interferon Type I / Q000008:administration & dosage*; D009369:Neoplasms / Q000628:therapy*; D011994:Recombinant Proteins / Q000008:administration & dosage
D007370:Interferon Type I; D011994:Recombinant Proteins; D004317:Doxorubicin